Context Therapeutics Inc. Common Stock

CNTX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

56M

Short interest (Jul 15)

7.2%

Net Short (Jul 27 ): -0.1%

Borrow Fee

0.83%

↓ 9.6%

Available Shares

↑ 27.6%

Price Chart

Company Overview

Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001842952

Asset Type: CS

Market Data

Market Cap: $56,423,002

Employees: 15

Status: Active

Short Interest

Current Borrow Fee 0.83%

Range: 0.83% - 0.83%

Available Shares 4M

Range: 2.5M - 3.8M

Recent Changes

Fee Change: ↓ 0.5%

Available Change: ↑ 5.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime